Share price at the NSE close on 23 Oct 2026. Previous close ₹594.70.
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7,150 Cr555th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 21 Jul 2026
- 34.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 20 May 2026
- 3.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 21 Jul 2026
- 11.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 21 Jul 2026
- 15.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 20 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,18,62749.9% delivered
Medplus Health Services board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing director and CEOGangadi Madhukar ReddyRelated to the promoter
- Company Secretary and Compliance OfficerShrenik Soni
6 directors4 independent2 executive
- Gangadi Madhukar Reddy · Chairperson and managing director and CEOExecutive · joined Nov 2006 · reappointed Aug 2026 · 1 listed board · 2 committee seats
- Cherukupalli Bhaskar ReddyExecutive · joined Oct 2023 · 1 listed board
- Aparna SurabhiIndependent · joined Jul 2024 · reappointed Jul 2024 · 27 months as independent · 3 listed boards · 3 as independent · 7 committee seats, 6 as chair
- Muralidharan ThyagarajanIndependent · joined Dec 2024 · reappointed Dec 2024 · 21 months as independent · 1 listed board · 1 as independent
- Ajit Pandurang RangnekarIndependent · joined May 2026 · reappointed May 2026 · 4 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- Mohanakrishna Reddy ArvabumiIndependent · joined May 2026 · reappointed May 2026 · 4 months as independent · 1 listed board · 2 as independent · 3 committee seats
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
2 directors who left
- Madhavan Ganesan, left 10 Jun 2026: Tenure Completion
- Murali Sivaraman, left 10 Jun 2026: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 10 Sep 20266 of 6 present4 independent · 48 days in between
- 23 Jul 20266 of 6 present4 independent · 1 day in between
- 21 Jul 20266 of 6 present4 independent · 61 days in between
- 20 May 20266 of 6 present4 independent
Audit Committee
Chair Aparna Surabhi
Mohanakrishna Reddy Arvabumi, Ajit Pandurang Rangnekar
- 21 Jul 20263 of 3 present3 independent · 61 days in between
- 20 May 20263 of 3 present3 independent
Nomination and remuneration committee
Chair Muralidharan Thyagarajan
Aparna Surabhi, Ajit Pandurang Rangnekar
- 21 Jul 20263 of 3 present3 independent · 61 days in between
- 20 May 20264 of 4 present4 independent
Stakeholders Relationship Committee
Chair Ajit Pandurang Rangnekar
Mohanakrishna Reddy Arvabumi, Gangadi Madhukar Reddy
- 20 May 20263 of 3 present1 independent
Risk Management Committee
Chair Ajit Pandurang Rangnekar
Muralidharan Thyagarajan, Mohanakrishna Reddy Arvabumi, Gangadi Madhukar Reddy
- 20 May 20266 of 6 present4 independent
Corporate Social Responsibility Committee
Chair Aparna Surabhi
Ajit Pandurang Rangnekar, Gangadi Madhukar Reddy
- 20 May 20264 of 4 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- B S R and CoPeer-review certificate valid to Apr 2029
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Medplus Health Services AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Medplus Health Services share news and announcements
Annual general meeting, 17 Aug 2026
79,127 shareholders on the register on 10 Aug 2026; present: 5 promoters and 134 others; votes counted by MS. RASHIDA ADENWALA / M/S R & A ASSOCIATES.The company's voting result (opens in a new tab)
To receive, consider and adopt the Audited Standalone & Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2026, and the Reports of the Board of Directors and Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 83.01% · promoters 100.00% · institutions 92.48% · other public 6.06%
- To appoint a Director in place of Dr. Cherukupalli Bhaskar Reddy (DIN: 00926550), Whole Time Director of the Company, who retires by rotation and being eligible, offers himself for re-appointment.Ordinary99.92% for0.08% against
Against: promoters 0.00% · institutions 0.17% · other public 0.07%
Turnout: all 82.93% · promoters 100.00% · institutions 92.55% · other public 5.27%
- Appointment of Mr. Mohan Krishna Reddy (DIN: 00093185) as an Independent Director of the CompanySpecial99.94% for0.06% against
Against: promoters 0.00% · institutions 0.11% · other public 0.06%
Turnout: all 83.04% · promoters 100.00% · institutions 92.55% · other public 6.06%
- Appointment of Mr. Ajit Pandurang Rangnekar (DIN: 01676516) as an Independent Director of the CompanySpecial85.68% for14.32% against
Against: promoters 0.00% · institutions 28.32% · other public 0.39%
Turnout: all 83.04% · promoters 100.00% · institutions 92.55% · other public 6.06%
- Re-appointment of Mr. Gangadi Madhukar Reddy (DIN: 00098097) as the Managing Director & CEO of the CompanyOrdinaryPromoters have an interest in it99.84% for0.16% against
Against: promoters 0.00% · institutions 0.27% · other public 0.06%
Turnout: all 70.27% · promoters 68.21% · institutions 92.55% · other public 6.06%
- Ratification of remuneration to M/s. M P R & Associates, Cost Accountants (Firm Registration No.: 000413), Cost Auditors of the Company for the financial year 2026-27.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 83.04% · promoters 100.00% · institutions 92.55% · other public 6.06%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 26 Mar 2026, 1 resolution
78,589 shareholders on the register on 20 Feb 2026; votes counted by R & A Associates / Rashida Hatim Adenwala.The company's voting result (opens in a new tab)
- Approval of Material Related Party Transactions between MedPlus Health Services Limited ("Company") and Optival Health Solutions Private Limited, its Material Subsidiary.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 40.13% · promoters 0.00% · institutions 90.53% · other public 6.01%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 15 Sep 2025, 5 resolutions
80,071 shareholders on the register on 8 Sep 2025; present: 1 promoter and 168 others; votes counted by MS. RASHIDA ADENWALA / M/S R & A ASSOCIATES.The company's voting result (opens in a new tab)
To receive, consider and adopt the Audited Standalone & Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2025, and the Reports of the Board of Directors and Auditors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 79.78% · promoters 100.00% · institutions 89.69% · other public 6.58%
- To appoint a Director in place of Dr. Cherukupalli Bhaskar Reddy (DIN: 00926550), Whole Time Director of the Company, who retires by rotation and being eligible, offers himself for re-appointmentOrdinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.02% · other public 0.01%
Turnout: all 79.78% · promoters 100.00% · institutions 89.69% · other public 6.58%
- Appointment of M/s. R & A Associates (Firm Registration No. P1994AP011100) Practicing Company Secretary as Secretarial Auditors of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 79.78% · promoters 100.00% · institutions 89.69% · other public 6.58%
- Approval of Material Related Party Transactions of the Company with Optival Health Solutions Private Limited a Material Subsidiary Company.Ordinary99.01% for0.99% against
Against: promoters 0.00% · institutions 1.00% · other public 0.01%
Turnout: all 38.98% · promoters 0.00% · institutions 89.69% · other public 3.57%
- Ratification of remuneration to M/s. M P R & Associates, Cost Accountants (Firm Registration No.: 000413), Cost Auditors of the Company for the financial year 2025-26.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 79.78% · promoters 100.00% · institutions 89.69% · other public 6.58%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 13 Mar 2025, 1 resolution
82,896 shareholders on the register on 7 Feb 2025; votes counted by R & A Associates / Rashida Hatim Adenwala.The company's voting result (opens in a new tab)
- Appointment of Mr. Thyagarajan Muralidharan (DIN: 00052097), as a Non-Executive Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 80.35% · promoters 100.00% · institutions 90.31% · other public 15.11%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 12 Mar 2025, 1 resolution
82,896 shareholders on the register on 7 Feb 2025; votes counted by R & A Associates / Rashida Hatim Adenwala.The company's voting result (opens in a new tab)
- Appointment of Mr. Thyagarajan Muralidharan (DIN: 00052097), as a Non-Executive Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 80.35% · promoters 100.00% · institutions 90.31% · other public 15.11%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 26 Sep 2024, 3 resolutions
Present: 2 promoters and 276 others.The company's voting result (opens in a new tab)
To receive, consider and adopt Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2024, and the Reports of Board of Directors and Auditors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 74.64% · promoters 100.00% · institutions 75.63% · other public 10.98%
- Appointment of Ms. Aparna Surabhi (DIN:01641633) as Non-Executive Independent Director of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 74.64% · promoters 100.00% · institutions 75.63% · other public 10.98%
- Ratification fo remuneration to M/s. M P R & Associates, Cost Accountants (Firm Registration No.:000413, Cost Auditors of the Company for the Financial Year 2023-24Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 74.64% · promoters 100.00% · institutions 75.63% · other public 10.98%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Meeting called by the tribunal, 15 Dec 2023, 1 resolution
Present: 0 promoters and 117 others.The company's voting result (opens in a new tab)
To consider and approve the Scheme of Amalgamation of MHS Pharmaceuticals Private Limited (“Transferor Company”) with MedPlus Health Services Limited (“Transferee Company/Company”) and their respective shareholders and creditors.MoreLess
Special100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 76.86% · promoters 100.00% · institutions 61.62% · other public 60.37%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 30 Nov 2023, 2 resolutions
The company's voting result (opens in a new tab)
- To consider and approve raising of funds and issuance of securities through Qualified Institutions Placement basis or through any other permissible modeSpecial99.01% for0.99% against
Against: promoters 0.00% · institutions 2.70% · other public 0.00%
Turnout: all 86.20% · promoters 100.00% · institutions 83.13% · other public 65.72%
- Appointment of Dr. Cherukupalli Bhaskar Reddy (DIN: 00926550) as a Whole-Time Director of the CompanySpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.04% · other public 0.00%
Turnout: all 85.67% · promoters 100.00% · institutions 83.46% · other public 62.64%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it
Mutual fund votes, meeting of 17 Aug 2026, 4 fund houses so far (houses' deadline to file 15 Oct 2026)
To receive, consider and adopt the Audited Standalone & Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2026, and the Reports of the Board of Directors and Auditors thereon.MoreLess
4 for0 against- To appoint a Director in place of Dr. Cherukupalli Bhaskar Reddy (DIN: 00926550), Whole Time Director of the Company, who retires by rotation and being eligible, offers himself for re-appointment.4 for0 against
- Appointment of Mr. Mohan Krishna Reddy (DIN: 00093185) as an Independent Director of the Company4 for0 against
- Appointment of Mr. Ajit Pandurang Rangnekar (DIN: 01676516) as an Independent Director of the Company
Against Angel One Mutual Fund
- Angel One Mutual FundPrior Approval not sought for appointment / continuation of Director above 75 years of age.
3 for1 against - Re-appointment of Mr. Gangadi Madhukar Reddy (DIN: 00098097) as the Managing Director & CEO of the Company4 for0 against
- Ratification of remuneration to M/s. M P R & Associates, Cost Accountants (Firm Registration No.: 000413), Cost Auditors of the Company for the financial year 2026-27.4 for0 against
Mutual fund votes, meeting of 26 Mar 2026, 16 fund houses
- Approval of Material Related Party Transactions between MedPlus Health Services Limited ("Company") and Optival Health Solutions Private Limited, its Material Subsidiary.16 for0 against
5 earlier meetings
Mutual fund votes, meeting of 15 Sep 2025, 19 fund houses
To receive, consider and adopt the Audited Standalone & Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2025, and the Reports of the Board of Directors and Auditors thereonMoreLess
19 for0 against- To appoint a Director in place of Dr. Cherukupalli Bhaskar Reddy (DIN: 00926550), Whole Time Director of the Company, who retires by rotation and being eligible, offers himself for re-appointment19 for0 against
- Appointment of M/s. R & A Associates (Firm Registration No. P1994AP011100) Practicing Company Secretary as Secretarial Auditors of the Company.19 for0 against
- Approval of Material Related Party Transactions of the Company with Optival Health Solutions Private Limited a Material Subsidiary Company.
Against Angel One Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, quant Mutual Fund
- Angel One Mutual FundTransparency concern: Unclear how the sale or purchase of property falls within the ordinary course of business.
- Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Transparency concern: Unclear how the sale or purchase of property falls within the ordinary course of business.
- quant Mutual FundCompliant with the law. Transparency concern: Unclear how the sale or purchase of property falls within the ordinary course of business.
15 for4 against - Ratification of remuneration to M/s. M P R & Associates, Cost Accountants (Firm Registration No.: 000413), Cost Auditors of the Company for the financial year 2025-26.19 for0 against
Mutual fund votes, meeting of 12 Mar 2025, 15 fund houses
- 1) Appoint Thyagarajan Muralidharan (DIN: 00052097) as Independent Director for five years from 18 December 2024.1 for0 against
Appointment of Mr. Thyagarajan Muralidharan(DIN: 00052097), as Non-Executive Independent Director of the Company, not liable to retire by rotation, for a period of five consecutive years with effect from December 18, 2024 to December 17, 2029.MoreLess
Against Groww Mutual Fund
- Groww Mutual FundNo concern on the merits of the proposed appointee. Non-Compliant with SEBI (LODR) & Companies Act, 2013: Terms and Conditions of the Independent Director not disclosed on the website.
12 for1 against- Elect Thyagarajan Muralidharan as Director1 for0 against
Mutual fund votes, meeting of 26 Sep 2024, 13 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
To receive, consider and adopt Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2024, and the Reports of Board of Directors and Auditors thereonMoreLess
13 for0 against- Appointment of Ms. Aparna Surabhi (DIN:01641633) as Non-Executive Independent Director of the Company13 for0 against
- Ratification fo remuneration to M/s. M P R & Associates, Cost Accountants (Firm Registration No.:000413, Cost Auditors of the Company for the Financial Year 2023-2411 for0 against
6 proposals not matched to one resolution
- 2) Reappoint Anish Kumar Saraf (DIN: 00322784) as Non-Executive Non-Independent Director, liable to retire by rotation.1 for0 against
- 4) Ratify remuneration of Rs. 130,000 per annum (excluding taxes and reimbursement of expenses) to M P R & Associates as cost auditors for FY24 and FY25.1 for0 against
- Ratify remuneration of Rs. 130,000 per annum (excluding taxes and reimbursement of expenses) to M P R & Associates as cost auditors for FY24 and FY251 for0 against
- Reappoint Anish Kumar Saraf (DIN: 00322784) as Non-Executive Non-Independent Director, liable to retire by rotation1 for0 against
- To appoint a Director in place of Mr. Anish Kumar Saraf (DIN: 00322784), Non - Executive Director of the Company, who retires by rotation and being eligible, offers himself for re-appointment.9 for0 against
- To approve, Re-appointment of Mr. Anish Kumar Saraf (DIN: 00322784), Non-Executive Director of the Company.1 for0 against
Mutual fund votes, meeting of 15 Dec 2023, 9 fund houses
To consider and approve the Scheme of Amalgamation of MHS Pharmaceuticals Private Limited (“Transferor Company”) with MedPlus Health Services Limited (“Transferee Company/Company”) and their respective shareholders and creditors.MoreLess
9 for0 against
Mutual fund votes, meeting of 30 Nov 2023, 8 fund houses
- To consider and approve raising of funds and issuance of securities through Qualified Institutions Placement basis or through any other permissible mode
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundCompliant with law. Governance concern: Excessive dilution. No specific justification.
7 for1 against - Appointment of Dr. Cherukupalli Bhaskar Reddy (DIN: 00926550) as a Whole-Time Director of the Company8 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Fines and tax disputes
Reported in the filing for the quarter to Sep 2026.
- Fine or penaltyOffice of the District Ground Water Officer, Ground Water Department, TelanganaSince 12 Jun 2026
Penalty of Rs. 5,000 was imposed under Telangana State Water, Land and Trees Act(TSWALTA), 2002
Penalty amount relates to extraction of ground water without permission. - Fine or penaltyJudical Magistrate (First Class) 42nd Court, MumbaiSince 1 Jul 2026
Fine of Rs. 10,000 was imposed under Section 394/471 of MMC Act 1888
Case relates to mandatory licencing requirements under Sec 394 and Sec 471 of MMC Act, 1888. - Fine or penaltyAsst Drug Controller-2, Raichur Circle, RaichurSince 31 Jul 2026
Fine imposed of Rs. 60,000 underSec 18(a)(iv) read with Rule 65(9)(a) punishable under section 27(d) of Drugs and cosmetics Act 1940
Sec 18(a)(iv) read with Rule 65(9)(a) punishable under section 27(d) of Drugs and cosmetics Act 1940 - Fine or penaltyGST Superitendent (CGST & CX Gr33 Circle 7 Kolkata Commissionerate)Since 24 Sep 2026
Penalty of Rs. 50,000/- was imposed.
Penalty amount of Rs.50,000/-was admitted during the course of audit for FY 2022-25 of Medplus health services limited in West Bengal State - Tax disputeSales Tax Officer, Bhubneshwar - 1 - Circle, Bhubneshwar, OdishaSince 28 May 2015The matter is pending before the tribunal, Odisha.
At the filing before: The Optival Health Solutions Private Limited (Subsidiary Company) has recevied an demand order of Rs. 21.48 Lacs towards tax liability for the Assessment: 01-04-2012 to 31.03.2014 (two years). The Company has filed an appeal before Joint Commissioner of Sales Tax, Bhubneshwar, Odisha on 25-05-2017 and the said authority pass a partly favorable order on 25.11.2017. The total demand amount was reduced to Rs. 7.32 Lacs. The Commissioner of Sales Tax, Bhubneshwar, Odisha also filed an appeal against the said order which is pending before the Tribunal.MoreLess
- Tax disputeDeputy Commissoner of State Tax (LTU-1), PUNE_LTU-510, Pune, Maharashtra.Since 23 Feb 2024The company has filed the second appeal before the Appellate Tribunal as on 16-06-2026 having Filing/Provisional Acknowledgment Number 2026127201000260. The matter is pending before the tribunal.
At the filing before: The Optival Health Solutions Private Limted (Subsidiary Company) has recevied an demand order of Rs. 50.42 Lacs towards tax liability. The Company has filed an appeal before Joint Commissioner of State Tax (LTU-1), PUNE_LTU-510, Pune, Maharashtra on 23-05-2024 Appeal Order 2018-19 received vide Order ref no.ZD271225008476F Dt:02.12.2025 Demand Tax Rs.4268359/- Interst Rs.5849814/- and Penalty Rs.500975/- (Total Demand of Rs.10619148/-) Against Appeal Order, The Company has paid addional Pred Deposit made and debited from GST cash ledger in order to file second appeal befor Tribunal of Rs.413,859/- (against Point no.3 and 4a) Amount admitted against Point no.4 and 5 and paid through GST Cash ledger of Rs. 307,781/- (Tax 140,545/- Interest Rs.83,618/- and Penalty Rs.83,618/-)MoreLess
- Tax disputeDeputy Commissoner of State Tax (LTU-1), PUNE_LTU-510, PuneSince 16 Aug 2024The matter is pending before the Joint Commissioner of State Tax (LTU-1), Pune , Maharashtra.
At the filing before: The Optival Health Solutions Private Limited (Subsidiary Company) has received an assessment order demanding Rs. 2,11,779,95/- (including tax Rs. 1,05,78,651, Interest Rs. 94,442,00 and Penalty Rs. 11,54,144) from Goods and Services Tax (GST) Department, Pune, Maharashtra for the assessment year 2019-20. ( Already Reported vide our letter 17.08.2024)MoreLess
- Tax disputeCommercial Tax Officer, Audit-4.8), DGSTO-4, Bangalore-95.Since 4 Apr 2024
The Appellate Joint Commissioner (ST), LGSTO 025 Bangaluru vide its order no. ZD290725023361G dated 07.07.2025 affirm the Demand order with tax liability amount of Rs. 4,06,030 plus Interest Rs. 3,39,597 and Penalty of Rs. 60,500. Appeal order received with the same demand. Appeal filed before the Appellate Tribunal in APL- 05 Dt: 30.06.2026. The matter is still pending before the tribunal.MoreLess
At the filing before: The Deccan Medisales Private Limted (Subsidiary Company) has recevied an order of Rs. 8,06,127 including (Interest & Penalty). The Company has filed an appeal before Joint Commissioner of State Tax Bangalore-95 on 02-07-2024 Against Appeal Order, The Company has paid Addional Pred Deposit of Rs.40602/- and debited from GST cash ledger in order to file second appeal befor Tribunal. Year 2018-19.MoreLess
13 more
- Tax disputeOffice of the Asst. Commissioner of Commercial Taxes, LGSTO-025, Bangalore-95Since 19 Jul 2024
The Appellate Joint Commissioner (ST), LGSTO 025 Bangaluru vide its order no. ZD2907250245348 dated 07.07.2025 affirm the Demand order with tax liability amount of Rs. 10,95,310 plus Interest Rs. 8,21,574 and Penalty of Rs. 1,09,534. Appeal filed before the Appellate Tribunal in APL- 05 Dt: 30.06.2026. The matter is still pending before the tribunal.MoreLess
At the filing before: The Deccan Medisales Private Limted (Subsidiary Company) has recevied an order of Rs. 20,26,418. The Company has filed an appeal before Joint Commissioner of State Tax Bangalore-95 on 26-09-2024 Against Appeal Order, The Company has paid Addional Pre- Deposit of Rs.109532/- and debited from GST cash ledger in order to file second appeal befor Tribunal. Year 2019-20.MoreLess
- Tax disputeCommercial Tax Officer, Jurisdiction: Kundrathur, Kancheepuram, TNSince 23 Dec 2025
Company filed Appeal before Appellate Authority against impugned order and Pre deposit made Rs.50,344/- (CGST Rs.251,72/- and SGST Rs.25,172/-). Appeal ARN no. AD330326049839P. Dated 18-05-2026. The matter is still pending before the Appellate Authority.MoreLess
At the filing before: MEDPLUS HEALTH SERVICES LIMITED (Holding Company) has recevied an GST DRC-07 order for the FY 2021-22 with Total Demand of Rs.8,87,210/- (Tax Rs.5,03,438/- Interest Rs. 3,33,428/- and Penalty Rs. 50,344/-) for Tamil Nadu state. Order Reference no.ZD331225357607B Dt:23.12.2025. Company filed Appeal before Appellate Authority against impugned order and Pre deposit made Rs.50,344/- (CGST Rs.251,72/- and SGST Rs.25,172/-)MoreLess
- Tax disputeCommercial Tax Officer, Jurisdiction: Kundrathur, Kancheepuram, TNSince 23 Dec 2025
Company filed Appeal before Appellate Authority against impugned order and Pre deposit made Rs.1,350/- (CGST Rs.675/- and SGST Rs.675/-). Appeal Reference No. AD330326050256C dated 18.05.2026.The matter is still pending before the Appellate Authority.MoreLess
At the filing before: MEDPLUS HEALTH SERVICES LIMITED (Holding Company) has recevied an GST DRC-07 order for the FY 2021-22 with Total Demand of Rs.43,776/- (Tax Rs.13,498/- Interest Rs. 10,278/- and Penalty Rs. 20,000/-) for Tamil Nadu state. Order Reference no.ZD331225357799W Dt:23.12.2025. Company filed Appeal before Appellate Authority against impugned order and Pre deposit made Rs.1,350/- (CGST Rs.675/- and SGST Rs.675/-)MoreLess
- Tax disputeSuperintendent, Jurisdiction: Ramanthapur, Amberpet, Secunderabad, TGSince 23 Dec 2025
Company filed Appeal before Appellate Authority against impugned order and Pre deposit made Rs.76,984/- (CGST Rs.20,125/- ,SGST Rs.20,125/- and IGST Rs.36,734/-). The matter is still pending before the Appellate Authority.MoreLess
At the filing before: VENKATA KRISHNA ENTERPRISES PRIVATE LIMITED (Subsidiary Company) has recevied an GST DRC-07 order for the FY 2021-24 with Total Demand of Rs.8,47,247/- (Tax Rs.7,69,844/-and Penalty Rs. 77,403/-) for Telangana state. Order Reference no.ZD361225087291D Dt:23.12.2025. Company filed Appeal before Appellate Authority against impugned order and Pre deposit made Rs.76,984/- (CGST Rs.20,125/- ,SGST Rs.20,125/- and IGST Rs.36,734/-)MoreLess
- Tax disputeSuperendent of CGST, Range III, Khardah Division, Kolkata North CommissionerateSince 18 Feb 2026GST Department filed an appeal before the Appellate Tribunal.
At the filing before: The Optival Health Solutions Private Limited (Subsidiary Company) had filed an appeal to Appellate Authority due to The assessing officer (SGST Authority) on February 23, 2023 disallowed the SGST credit of Rs. 36,88,297/- against the TRANS-2 return filed by the Company. Company has received favourable Appeal Order. In relation to Appeal Order; GST Department file 2nd appeal before the Appellate Tribunal against the the first appellate order which was issued favorable order amount of Rs.36,88,297/- on Feb 18, 2026, having file number 2026061101000014 and case number 16/APL/2026.MoreLess
- Tax disputeSuperendent of CGST, Range III, Khardah Division, Kolkata North CommissionerateSince 13 Feb 2026GST Department filed an appeal before the Appellate Tribunal.
At the filing before: The Optival Health Solutions Private Limited (Subsidiary Company) had filed an appeal to Appealate authority due to The assessing officer (CGST Authority) on February 23, 2023 disallowed the SGST credit of Rs. 65,90,636/- millions against the TRANS-2 return filed by the Company. Company has received favourable Appeal Order. In relation to Appeal Order; GST Department file an appeal before the Appellate Tribunal against the the first appellate order which was issued favorable order amount of Rs.65,90,636/- on Feb 18, 2026, having file number 2026061101000010 and case number 13/APL/2026.MoreLess
- Tax disputeIncome Tax Department, Assessment UnitSince 29 Dec 2022The Company is yet to receive hearing notice.
At the filing before: Assessment Order U/s 143(3) on 29/12/22 for the AY:2021-22 received from Assessment Unit, Income Tax Department with a disputed tax amount of INR 3.48 Crores. We have filed an Appeal with CIT(A) against the Order of AO on 25/01/23. We have filed our written submission also.MoreLess
- Tax disputeIncome Tax Department, Assessment UnitSince 29 Dec 2022The Company is yet to receive hearing notice.
At the filing before: Penalty Show Cause notice U/s 174 read with section 270A on 29/12/22 for the AY:2021-22 received from Assessment Unit, Income Tax Department for the outstanding demand. We have filed our reply against SCN on 08/02/23 saying that we have filed appeal with CIT(A) on 25/01/23 against the Order of AO.MoreLess
- Tax disputeIncome Tax DepartmentSince 28 Feb 2015Order is pending from AO.
At the filing before: Assessment Order U/s 143(3) on 28/02/15 for the AY:2012-13 received from ITO, Income Tax Department with disputed tax amount of INR 0.60 Crores. We have filed an Appeal with CIT(A) against the Order of AO on 06/05/15. After hearing we have received Appeal Order on 01/11/2019 with partly allowed. On 10/01/2020 we have filed Appeal with ITAT against the order of CIT(A). The case is remanded back to CIT(A) for further verification. Received order from CIT(A) on 16/09/26 and allowed our one ground without any further verification and allowed other two graounds with limited verification by the AO. Order from the AO giving effect to the order of CIT(A) is pending.MoreLess
- Tax disputeIncome Tax DepartmentSince 31 Dec 2016Order is pending from CIT(A).
At the filing before: Assessment Order U/s 143(3) on 31/12/16 for the AY:2013-14 received from Assessing Officer, Income Tax Department with a disputed tax amount of INR 2.60 Crores. We have filed an Appeal with CIT(A) against the Order of AO on 15/02/17. We have submitted our written submissions.MoreLess
- Tax disputeIncome Tax DepartmentSince 31 Dec 2019Order is pending from CIT(A).
At the filing before: Assessment Order U/s 143(3) on 31/12/19 for the AY:2017-18 received from Assessing Officer, Income Tax Department with a disputed tax amount of INR 8.30 Crores. We have filed an Appeal with CIT(A) against the Order of AO on 29/01/20. We have submitted our written submissions. Hearing date is yet to be received.MoreLess
- Tax disputeIncome Tax DepartmentSince 29 Sep 2022The Company is yet to receive hearing notice.
At the filing before: Assessment Order U/s 143(3) on 29/09/22 for the AY:2020-21 received from Assessing Officer, Income Tax Department with a disputed tax amount of INR 43.45 Crores. The Company filed a writ petition with Telangana High Court on 12/10/22. Hearing done partly and now further postponed to 11/02/25. Finally hearing done on 22/04/25 & 23/04/25 and the matter is reserved for the Order from the High Court. High Court Judgement came on 21/11/25 in fafour of the Company and our writ perition stands allowed by the High Court. But in December 2025, Department has filed review petition against the favourable order from the Court. We have filed counter affidavit against the review petition by the Department on 02/04/2026. Hearing fixed for 09/04/26 but could not happen and further date of hearing was 17th August 2026. The company is yet to receive the hearing notice.MoreLess
- Tax disputeThe Regional P.F. Commissioner- I, Pune-I, Employee Provident Fund Organisation (through Enforcement Officers)Since 31 Jan 2024The matter is pending before the Central Goverment Industrial Tribunal (CGIT) Mumbai-2 Maharashtra and the next hearing scheduled on 04.01.2027.
At the filing before: The Optival Health Solutions Private Limted (Subsidiary Company) has recevied an demand order of Rs. 1,88,96, 802/- (Rs. One Crore eighty eight lakhs ninety six thousand eight hundred two) for the period from 2017 to 2022 for violation of subsidy under EPF Scheme, 1952, read with 14B and 7Q to be deposited within 60 days of the orderMoreLess
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Mar 2026. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesDec 2021, checked by Axis Bank Limited | 578.93 | – | – | No |